+613,227.2%
NVDA vs CVS
+522.1%
+612,705.2%
-89.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.8% | -0.5% | +1.3% | +1.0% |
| 7D | +5.9% | +4.0% | +1.9% | +4.7% |
| 30D | +5.1% | -2.4% | +7.5% | +5.6% |
| 3M | +5.4% | +2.7% | +2.7% | +4.1% |
| 6M | +26.0% | +21.9% | +4.1% | +18.3% |
| YTD | +23.7% | +24.7% | -1.1% | +14.6% |
| 1Y | +34.4% | +35.4% | -1.1% | +21.2% |
| 3Y | +375.8% | +65.2% | +310.6% | +286.8% |
| 5Y | +911.8% | +30.5% | +881.2% | +778.6% |
| 10Y | +14,899.8% | +40.4% | +14,859.4% | +12,118.4% |
| All | +613,227.2% | +522.1% | +612,705.2% | +334,913.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling